close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Biotech and Pharmaceuticals Healthy Returns Viking Therapeutics Inc
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Inflation World Markets Alzheimer's disease
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Nasdaq Inc Market Outlook Eli Lilly and Co
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Pharmaceuticals Business Business News
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Alnylam Pharmaceuticals Inc Eaton Corporation PLC ETF Edge
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Healthy Returns Biotech and Pharmaceuticals Viking Therapeutics Inc
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Business News Stock Picks Business
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Asia: Top News and Analysis US Top News and Analysis Novo Nordisk A/S
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Eli Lilly and Co Novo Nordisk A/S Health & Science
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Eli Lilly and Co Biotechnology Health & Science
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Pharmaceuticals Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health care industry Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Novo Nordisk A/S Eli Lilly and Co Alphabet Inc
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags stocks Markets Eli Lilly and Co
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Eli Lilly and Co Biotechnology Health & Science
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Investing U/S/ Markets Casey's General Stores Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Pfizer Inc Health care industry Merck & Co Inc
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Breaking News: Technology Internet Technology
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Breaking News: Technology Technology Alphabet Inc
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Weight loss diets Weight management Personnel
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Biotechnology Health & Science Novo Nordisk A/S
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags ETF Edge Exchange/traded funds Stock markets
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Health & Science Breaking News: Technology Novo Nordisk A/S
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Pharmaceuticals Biotech and Pharmaceuticals Business News
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Market Outlook stocks Markets
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investing Fusion Pharmaceuticals Inc Breaking News: Investing
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health & Science Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Eli Lilly and Co Novo Nordisk A/S Carmot Therapeutics Inc
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Alphabet Inc Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Biotech and Pharmaceuticals Companies US: News
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.